Trigeminal neuropathy: Gd-DTPA enhanced MR imaging.
A review of 17 patients with Gd-DTPA enhancing lesions of the trigeminal nerve (6 patients with benign tumors, 4 with inflammatory disease, 7 with malignant tumors) was conducted to determine if contrast enhanced MR imaging is superior to nonenhanced imaging and to identify imaging characteristics that aid in separating benign and malignant disease. Contrast enhanced imaging appears to be superior to nonenhanced imaging in patients with intrinsic fifth nerve lesions. Malignant lesions are suggested by enlarged, enhancing fifth nerves with irregular margins and benign lesions by minimal or no enlargement with smooth margins. Overlap of imaging findings between benign and malignant disease strongly suggests that follow-up imaging and clinical findings are of utmost importance. Gadolinium-enhanced MR imaging of the fifth nerve is recommended in patients with trigeminal sensory or motor deficits as well as those with atypical trigeminal neuralgia.
Sevick
R J
RJ
Department of Radiology, University of California, San Francisco.
Dillon
W P
WP
Engstrom
J
J
Bergman
W G
WG
Harnsberger
H R
HR
D000293:Adolescent; D000328:Adult; D002648:Child; D003287:Contrast Media; D003389:Cranial Nerve Diseases / Q000175:diagnosis; D003390:Cranial Nerve Neoplasms / Q000175:diagnosis*; D005260:Female; D005682:Gadolinium; D019786:Gadolinium DTPA; D006801:Humans; D008279:Magnetic Resonance Imaging / Q000379:methods*; D008297:Male; D008875:Middle Aged; D009942:Organometallic Compounds; D004369:Pentetic Acid; D014276:Trigeminal Nerve
D003287:Contrast Media; D009942:Organometallic Compounds; D004369:Pentetic Acid; D005682:Gadolinium; D019786:Gadolinium DTPA